COMPARATIVE EFFECTS OF DRY NEEDLING AND NEURAL MOBILIZATION ON PAIN, STRENGTH AND RANGE OF MOTION… (NCT07643740) | Clinical Trial Compass
CompletedNot Applicable
COMPARATIVE EFFECTS OF DRY NEEDLING AND NEURAL MOBILIZATION ON PAIN, STRENGTH AND RANGE OF MOTION IN PATIENTS WITH GOLFER'S ELBOW
Pakistan29 participantsStarted 2025-01-01
Plain-language summary
This randomized clinical trial aims to compare the effectiveness of Dry Needling and Neural Mobilization in patients diagnosed with Golfer's Elbow (Medial Epicondylitis). The study will evaluate the effects of both interventions on pain intensity, grip strength, and range of motion. Participants will be randomly allocated to either the Dry Needling group or the Neural Mobilization group and treated over a specified intervention period. Outcome measures will be assessed at baseline and after treatment to determine which intervention provides greater improvement in pain reduction, muscle strength, and functional mobility. The results may contribute to evidence-based rehabilitation strategies for managing Golfer's Elbow
Who can participate
Age range
18 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Both male and female patients were included.
* Diagnosis of Medial Epicondylitis by spiral test clinically confirmed by orthopaedic.
pain is limited on medial epicondyle
* Pain reproduced with resisted wrist flexion and/or forearm pronation.
* Aged between 18-40 years
* Acute to Subacute stage (≥ 6 weeks and ≤ 12 months
* NPRS score ≥ 4/10 at baseline
Exclusion Criteria:
* • History of Other elbow pathologies e.g (Lateral epicondylitis , Olecranon bursitis ,Ligament injuries)
* Radial or ulnar neuropathies not associated with medial epicondylitis.
* Systemic or inflammatory conditions affecting tendons, such as rheumatoid arthritis
* Diabetes with neuropathy (unless controlled and neuropathy absent)
* Previous surgical procedures around the elbow or wrist within the past 6 months
* Corticosteroid injection, PRP or shockwave therapy within the last 3 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pain intensity
Timeframe: Baseline and at 6 weeks post-intervention